Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.

[1]  C. Dollery,et al.  The clinical pharmacology of beta-adrenoceptor-blocking drugs. , 1976, Progress in cardiovascular diseases.

[2]  J. Thomas,et al.  The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol. , 1976, British journal of clinical pharmacology.

[3]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[4]  E. Sellers,et al.  Drug therapy. Binding of drugs to serum albumin (second of two parts). , 1976, The New England journal of medicine.

[5]  K. Palmer,et al.  Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics. , 1975, British Journal of Clinical Pharmacology.

[6]  F. Abboud,et al.  Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. , 1975, The Journal of clinical investigation.

[7]  P. Kligfield,et al.  Noninvasive assessment of clinical response to oral propranolol therapy. , 1975, The American journal of cardiology.

[8]  N. Dyer,et al.  Fibrinous peritonitis: a complication of practolol therapy. , 1975, British medical journal.

[9]  P. Wright.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome. , 1975, British medical journal.

[10]  R. Elofsson,et al.  Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins. , 1974, Acta pharmaceutica Suecica.

[11]  R. Shanks,et al.  Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate , 1974, Clinical pharmacology and therapeutics.

[12]  R. Lefkowitz.  Selectivity in Beta‐Adrenergic Responses: Clinical Implications , 1974 .

[13]  Singh Bn.  Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology. , 1973 .

[14]  J. Eastwood,et al.  Pharmacodynamics of Practolol in Chronic Renal Failure , 1973, British medical journal.

[15]  D. Maxwell,et al.  β‐Adrenoceptor blocking properties and cardioselectivity of M & B 17,803A , 1973, British journal of pharmacology.

[16]  J. Fitzgerald.  Cardioselective beta-adrenergic blockade. , 1972, Proceedings of the Royal Society of Medicine.

[17]  W. Roberts,et al.  The clinical triad of traumatic ventricular septal defect, occlusion of left anterior descending coronary artery and ventricular aneurysm , 1972 .

[18]  E. Amsterdam,et al.  Comparison of the beta adrenergic blocking properties and negative inotropic effects of oxprenolol and propranolol in patients , 1972 .

[19]  D. Shand,et al.  Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats , 1971, British medical journal.

[20]  H. Brunner,et al.  Pharmacological aspects of oxprenolol. , 1970, Postgraduate medical journal.

[21]  M. Cosgrove,et al.  The metabolism and distribution of the selective adrenergic beta blocking agent, practolol. , 1970, The Journal of pharmacology and experimental therapeutics.

[22]  J. Melnick,et al.  Au-antigen particles. , 1970, Lancet.

[23]  C. Dollery,et al.  Clinical pharmacology of beta‐receptor‐blocking drugs , 1969, Clinical pharmacology and therapeutics.

[24]  A. Barrett,et al.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.

[25]  R. S. Mcneill,et al.  A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol. , 1968, British journal of anaesthesia.

[26]  A. M. Lands,et al.  Differentiation of Receptor Systems activated by Sympathomimetic Amines , 1967, Nature.

[27]  J. S. Stephenson,et al.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). , 1962, Lancet.

[28]  C E POWELL,et al.  Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. , 1958, The Journal of pharmacology and experimental therapeutics.

[29]  R. Ahlquist,et al.  A study of the adrenotropic receptors. , 1948, The American journal of physiology.

[30]  C. Regårdh,et al.  Clinical Pharmacokinetics of β-Adrenoceptor Blocking Drugs , 1976 .

[31]  W. Frishman,et al.  Non-invasive assessment of clinical response to oral propranolol , 1974 .

[32]  W. Riess,et al.  The metabolites of oxprenolol (Trasicor) in man. , 1974, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  R G Shanks,et al.  Selective blockade of adrenoceptive beta receptors in the heart. , 1968, British journal of pharmacology and chemotherapy.